16.11 USD
-0.29
1.77%
At close Dec 6, 4:00 PM EST
After hours
16.11
+0.00
0.00%
1 day
-1.77%
5 days
-3.59%
1 month
-9.95%
3 months
-0.25%
6 months
0.06%
Year to date
-24.33%
1 year
-23.69%
5 years
-45.07%
10 years
-33.13%
 

About: Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medicine, other health sciences, and other undergraduate programs, Continuing Education provides specialization programs and graduate courses in medicine; and Digital Services provides content and technology for medical education, clinical decisions software, practice management tools (that encompass electronic medical records, telemedicine, and digital prescription, and provides access, demand and efficiency for the healthcare players.

Employees: 10,181

0
Funds holding %
of 6,790 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

6,800% more call options, than puts

Call options by funds: $207K | Put options by funds: $3K

100% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 11

17% more funds holding

Funds holding: 63 [Q2] → 74 (+11) [Q3]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q2] → 1 (+0) [Q3]

9% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 23

9.62% less ownership

Funds ownership: 33.61% [Q2] → 23.99% (-9.62%) [Q3]

28% less capital invested

Capital invested by funds: $262M [Q2] → $190M (-$72.5M) [Q3]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$16
1%
downside
Avg. target
$16
1%
downside
High target
$16
1%
downside

1 analyst rating

positive
0%
neutral
0%
negative
100%
Goldman Sachs
Gustavo Miele
0% 1-year accuracy
0 / 1 met price target
1%downside
$16
Sell
Initiated
3 Dec 2024

Financial journalist opinion

Based on 4 articles about AFYA published over the past 30 days

Positive
Seeking Alpha
6 days ago
Afya Continues To Be An Opportunity Even After Brazil's Depreciation
Afya's 3Q24 results showed 12% organic revenue growth and 16% overall growth, driven by the Unidom acquisition and strong performance in medical education and software segments. The company leveraged its cost structure, achieving a 300bps increase in adj EBITDA margin and a 68% YoY net income growth despite higher financial costs. Afya's valuation remains attractive, with a P/E of 11x and a potential yield of 20% in a few years, justifying a Buy rating.
Afya Continues To Be An Opportunity Even After Brazil's Depreciation
Negative
Zacks Investment Research
3 weeks ago
Afya (AFYA) Q3 Earnings Miss Estimates
Afya (AFYA) came out with quarterly earnings of $0.32 per share, missing the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.28 per share a year ago.
Afya (AFYA) Q3 Earnings Miss Estimates
Neutral
Business Wire
3 weeks ago
Afya Limited Third Quarter and Nine Months 2024 Financial Results
NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today financial and operating results for the three and nine-month periods ended September 30, 2024 (third quarter 2024). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Third Quarter 2024 Highlights 3Q24 Net.
Afya Limited Third Quarter and Nine Months 2024 Financial Results
Neutral
Business Wire
3 weeks ago
Afya Limited to Report Third Quarter and Nine Months 2024 Financial Results on November 13th
NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, announced today that it will report third-quarter and nine months 2024 financial results for the period ended September 30th, 2024, following the close of the market on Wednesday, November 13th, 2024 and will host a corresponding conference call and webcast at 05:00 pm EST. A live and archived webcast of the.
Afya Limited to Report Third Quarter and Nine Months 2024 Financial Results on November 13th
Neutral
Zacks Investment Research
2 months ago
Is the Options Market Predicting a Spike in AFYA Stock?
Investors need to pay close attention to AFYA stock based on the movements in the options market lately.
Is the Options Market Predicting a Spike in AFYA Stock?
Neutral
Business Wire
2 months ago
Afya Limited to Host Afya Day 2024 on October 29th | Hybrid Event
NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, today announced that it will host its Afya Day on October 29th, 2024. The event will be held in a hybrid format, combining both in-person and online participation, and will feature presentations from Afya's executive team, covering the Company's growth, business strategy and future outlook. Event Details: Da.
Afya Limited to Host Afya Day 2024 on October 29th | Hybrid Event
Neutral
Business Wire
2 months ago
Afya Assumes a Voluntary Commitment to Free Health Consultations
NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, announced a public commitment to achieve 5 million free health consultations by 2030, in line with Sustainable Development Goal 3 (SDG 3), which aims to ensure healthy lives and promote well-being for all people, at all ages. To serve the communities and achieve the estimated results, Afya intends to increas.
Afya Assumes a Voluntary Commitment to Free Health Consultations
Neutral
Business Wire
3 months ago
Afya Limited Announces MEC Decision on Medical Seats Reconsideration in Unigranrio
NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, today announced that following the conclusion of an administrative procedure, the Ministry of Education (“MEC”), has granted the request for reconsideration submitted by Universidade do Grande Rio Professor José de Souza Herdy (“Unigranrio”). Per the e-MEC portal, Unigranrio reestablished 10 medical seats in.
Afya Limited Announces MEC Decision on Medical Seats Reconsideration in Unigranrio
Neutral
Business Wire
3 months ago
Afya Secures Full Disbursement of R$500 Million From IFC to Support the Company's Expansion
NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil announced today that its wholly-owned subsidiary, Afya Participações S.A., has received the total disbursement of BRL500.0 million under the loan agreement with International Finance Corporation ("IFC") to support the Company's expansion program. The financing is IFC's first sustainability-linked loan based o.
Afya Secures Full Disbursement of R$500 Million From IFC to Support the Company's Expansion
Positive
Seeking Alpha
3 months ago
Afya: Q2 2024 Was Not Surprising, Still An Opportunity Despite New Info On Market Supply
Afya's Q2 2024 results showed stable operations with 14% revenue growth, driven by increased enrollment and tuition, and improved operating margins. A favorable Supreme Court ruling on medical seat openings and new financing from the IFC are positive developments for Afya. Despite short-term stability, long-term concerns arise due to potential oversupply in Brazil's medical education and profession markets.
Afya: Q2 2024 Was Not Surprising, Still An Opportunity Despite New Info On Market Supply
Charts implemented using Lightweight Charts™